Voûte Pa

131I-metaiodobenzylguanidine (131I-MIBG) therapy for residual neuroblastoma: a mono-institutional experience with 43 patients

Local therapy in localized Ewing tumors: results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials

Perspectives on cancer therapy-induced mucosal injury

Endoprosthetic Reconstruction in 250 Patients with Sarcoma

Relation between dissolution profiles and toxicity of cisplatin-loaded microspheres

Chemotherapeutic adjuvant treatment for osteosarcoma: Where do we stand?

International Collaboration is Feasible in Trials for Rare Conditions: The EURAMOS Experience

Preoperative versus postoperative radiotherapy in soft-tissue sarcoma of the limbs: a randomised trial

Prognostic factors in localized Ewing's tumours and peripheral neuroectodermal tumours: the third study of the French Society of Paediatric Oncology (EW88 study)

Revisions of the international criteria for neuroblastoma diagnosis, staging, and response to treatment.

Soft-Tissue Sarcomas in Adults

Platinum disposition after intraarterial and intravenous infusion of cisplatin for osteosarcoma

Multiple Primary Cancers in Families With Li-Fraumeni Syndrome

Incidence patterns of soft tissue sarcomas, regardless of primary site, in the surveillance, epidemiology and end results program, 1978–2001: An analysis of 26,758 cases

Osteosarcoma

Osteosarcoma treatment – Where do we stand? A state of the art review

Analysis of chromosome breakpoints in neuroblastoma at sub‐kilobase resolution using fine‐tiling oligonucleotide array CGH

Neuroblastoma

Prescribing Personalized Nutrition for Cardiovascular Health: Are We Ready?

International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma.

131I MIBG therapy in neuroblastoma: Mechanisms, rationale, and current status

Severe oral mucositis after therapeutic administration of [131I]MIBG in a child with neuroblastoma

Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee

A systematic review and evaluation of the use of tumour markers in paediatric oncology: Ewing's sarcoma and neuroblastoma

Visualization of a ganglioneuroma by means of scintigraphy with 131-I-MIBG

Osteosarcoma: Current Treatment and a Collaborative Pathway to Success

The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report

Localized Ewing Tumor of Bone: Final Results of the Cooperative Ewing’s Sarcoma Study CESS 86

EICESS 92 (European Intergroup Cooperative Ewing's Sarcoma Study) - Erste Ergebnisse

Pretreatment with [131I] Metaiodobenzylguanidine and Surgical Resection of Advanced Neuroblastoma

Die GPO cooperativen Ewing-Sarkom Studien CESS 81/86:

Three germline mutations in theTP53 gene

Total-body scintigraphy with 131I-meta-iodobenzylguanidine for detection of neuroblastoma.

Preoperative [131I]metaiodobenzylguanidine therapy of neuroblastoma at diagnosis ("MIBG de novo").

Phase II study of cisplatin in advanced osteogenic sarcoma. European Organization for Research on Treatment of Cancer Soft Tissue and Bone Sarcoma Group.

Chromosome 1p allelic loss in neuroblastoma: prognosis, genomic imprinting and 1;17 translocations.

Detection of neuroblastoma with 131I-meta-iodobenzylguanidine.